November 4-5, 2013 | Boston Marriott Cambridge | Cambridge, MA
Cancer tumor cells actively shed exosomes and microvesicles containing a cargo of proteins, lipids and nucleic acids into the tumor microenvironment and bodily fluids. Because these vesicles are present in elevated levels in the blood, exhibit stability and reflect the cell of origin, there is potential for use in the diagnosis and monitoring of progression of a wide variety of cancers. Cambridge Healthtech Institute’s Second Annual Exosomes and Microvesicles in Cancer meeting will cover recent research in their role in the formation of the pre-metastatic niche, cell-to-cell communication, and control of tumor-associated immune response. It will also explore the potential of exosomes and microvesicles in cancer diagnostic and therapeutic development.
- Role of exosomes in cancer progression
- Molecular profiling of exosomes and microvesicles
- Utility as diagnostic and prognostic biomarkers in cancer
- Exosomes and microvesicles as extracellular messengers
- Technologies for exosome isolation and characterization
- Applications in cancer therapy
Scientists who wish to present their knowledge and expertise to their colleagues are asked to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program.
If you are interested in presenting, please click here to submit your proposal.
Deadline for submission is Friday, May 3, 2013
For more information, please contact:Julia Boguslavsky
Executive Director, Conferences
For sponsorship information, please contact:Ilana Quigley
Manager, Business Development